New mRNA vaccines show promise in fighting cancer, extending lives in trials. However, funding uncertainties threaten progress despite over 626,000 projected U.S. cancer deaths this year. Research continues, but financial hurdles remain significant.
mRNA Cancer Vaccines Advance Amid Funding Debate
✨ Enjoying this article? ✨
📱 Get more with the NewsNuggs iOS App →